Next 10 |
home / stock / kykof / kykof news
2024-03-20 12:11:15 ET More on Kyowa Kirin Kyowa buyout Orchard wins FDA nod for rare disease therapy Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial information for Kyowa Kirin Read the full article on Seeking ...
2024-03-19 10:44:51 ET More on Kyowa Kirin Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial information for Kyowa Kirin Historical earnings data for Kyowa Kirin Co., Ltd. Financial information for Kyowa Kirin Co., ...
2024-02-07 17:44:04 ET More on Kyowa Kirin Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial information for Kyowa Kirin Read the full article on Seeking Alpha For further details see: Kyowa Kirin reports FY res...
2023-12-14 12:30:25 ET The Biden administration on Thursday named 48 Medicare Part B drugs that could be subject to inflation penalties for Q1 2024, including products from the likes of AbbVie ( NYSE: ABBV ), Amgen ( NASDAQ: AMGN ), and Pfizer ( NYSE: PFE ). Drug...
2023-12-04 07:02:21 ET Summary Kyowa Kirin is acquiring Orchard Therapeutics for $16 per share and a CVR worth up to $1, adding up to a $350 million deal. The acquisition comes after extensive research collaboration and will allow Kyowa to accelerate research programs. The CVR...
2023-11-01 10:27:34 ET More on Kyowa Kirin Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating Ardelyx gains as Japan approves kidney disease therapy Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial ...
2023-10-31 14:29:47 ET More on Ardelyx Ardelyx, Inc. (ARDX) Q3 2023 Earnings Call Transcript Ardelyx: XPHOZAH Is No Niche Product Rising Sun Over Ardelyx: A Tenapanor Tale (Rating Upgrade) Biggest stock movers today: Morgan Stanley, Spirit AeroSystems, United...
2023-10-05 05:48:00 ET NASDAQ: RIVN plunged more than 9% Related stories BlackBerry Limited (BB) Q2 2024 Earnings Call Transcript Does Rivian Still Have An Existential Crisis? BlackBerry Earnings Preview: Pre-Announcement May Not Save Further Sell-Off ...
2023-09-25 07:21:20 ET More on Ardelyx Seeking Alpha’s Quant Rating on Ardelyx Historical earnings data for Ardelyx Financial information for Ardelyx Ardelyx: Niche Products For Competitive Markets Cantor upgrades Ardelyx to overweight ahead of...
2023-09-24 23:33:31 ET Summary Kyowa Kirin shares are viewed as a cheap option on the positive outcome for the atopic dermatitis drug being developed with Amgen. The company's recent track record for new drug trial success has been poor, but the partnership with Amgen provides rea...
News, Short Squeeze, Breakout and More Instantly...
Kyowa Hakko Kogyo Company Name:
KYKOF Stock Symbol:
OTCMKTS Market:
TOKYO , Jan. 6, 2020 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) President and CEO: Masashi Miyamoto , "Kyowa Kirin") today announces that its marketing authorisation application (MAA) for istradefylline (KW-6002) as an adjunctive treatment to levodopa-based regimens in adult patie...